MA vs SER · P/E 38, rev $32.79B vs rev $56.0K
Mastercard Inc (MA) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
Mastercard Inc (MA) is a credit services company listed on US. It is led by Michael Miebach.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported MA revenue for 2025-12-31 was $32.79B. Net income was $14.97B. Revenue was up 16.4% from 2024-12-31 to 2025-12-31. MA currently screens at market cap $515.12B and trailing P/E 38.4.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
MA currently screens at market cap $515.12B and trailing P/E 38.4. SER currently screens at market cap $29.7M.
Not investment advice. Open the MA and SER stock pages for the full models.
Not investment advice.